v3.26.1
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes

10. Income Taxes

For the years ended December 31, 2025 and 2024, the Company has a full valuation allowance against the deferred tax assets.

The following table presents the domestic and foreign components of (Loss) income before (benefit) provision for income taxes for the periods indicated (in thousands):

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

 

 

 

 

 

 

Domestic

 

$

(11,167

)

 

$

(8,754

)

 

 

 

 

 

 

(Loss) income before (benefit) provision for income taxes

 

$

(11,167

)

 

$

(8,754

)

 

(Benefit) provision for income taxes consisted of the following for the periods indicated (in thousands):

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

Current:

 

 

 

 

 

 

Federal

 

$

-

 

 

$

-

 

State

 

 

2,450

 

 

 

1,715

 

Total Current

 

 

2,450

 

 

 

1,715

 

Deferred:

 

 

 

 

 

 

Federal

 

 

-

 

 

 

-

 

State

 

 

-

 

 

 

-

 

Total Deferred

 

 

-

 

 

 

-

 

Total Provision

 

$

2,450

 

 

$

1,715

 

The differences between the tax provision (benefit) at the U.S. federal statutory income tax rate to the unrecognized income tax expenses and the U.S. statutory income tax rate to our effective tax rates are as follows (in thousands):

 

 

Year Ended December 31,

 

 

 

2025

 

 

 

 

Amount

 

 

%

 

 

U.S. Federal Statutory Income Tax (Benefit)

 

 

(2,345

)

 

 

21.0

%

 

 

 

 

 

 

 

 

 

State and local income taxes, net of federal benefit (1)

 

 

(569

)

 

 

5.1

%

 

Change in valuation allowance

 

 

3,040

 

 

 

(27.2

%)

 

Nontaxable / nondeductible items (permanent items)

 

 

91

 

 

 

(0.8

%)

 

Fair value adjustment on common warrants

 

 

(192

)

 

 

1.7

%

 

State deferred tax adjustments, net of federal benefit

 

 

173

 

 

 

(1.5

%)

 

Change in state tax rate, net of federal benefit

 

 

310

 

 

 

(2.8

%)

 

Changes in unrecognized tax benefits / prior-period positions

 

 

(668

)

 

 

6.0

%

 

Other

 

 

167

 

 

 

-1.5

%

 

Income Tax Provision/(Benefit) and Effective Income Tax Rate

 

 

(5

)

 

 

-

%

 

 

 

$

2

 

 

 

-

%

 

 

(1) For the year ended December 31, 2025, the net state income tax benefit includes deferred tax effects from temporary differences primarily in California, Illinois, and New Jersey, offset by current state income tax expense in California and New Jersey. These jurisdictions collectively represent more than 50% of the net state and local income tax effect.

 

The following is a reconciliation of the United States federal income tax statutory rate to the Company's effective income tax rate for the year ended December 31, 2024 as previously disclosed and prior to the adoption of ASU No. 2023-09 (in thousands).

 

 

Year Ended December 31,

 

 

 

2024

 

 

 

 

Amount

 

 

U.S. Federal Statutory Income Tax (Benefit)

 

 

(1,838

)

 

Increase (decrease) resulting from:

 

 

 

 

Change in valuation allowance

 

 

4,034

 

 

Permanent items

 

 

(330

)

 

Tax credits

 

 

(456

)

 

State

 

 

(1,410

)

 

Income Tax Provision/(Benefit) and Effective Income Tax Rate

 

 

-

 

 

 

Our effective income tax rates for the years ended December 31, 2025, and December 31,2024, are same at 0%. The Company’s annual effective tax rate for the year ended December 31, 2025, and December 31, 2024 differs from the statutory rate of 21% primarily because the Company is only liable for minimum taxes in a handful of states, deferred tax adjustments, impacts from fair value adjustments of warrant liability, and the change in valuation allowance.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. Certain provisions of OBBBA became effective during 2025, while other provisions will become effective in periods subsequent to 2025. The Company has evaluated the provisions of OBBBA applicable to its operations and, based on its assessment as of December 31, 2025, has determined the impact on its financial statements to be immaterial. The Company will continue to monitor developments and evaluate the effects of any additional guidance or interpretive regulations issued in connection with OBBBA.

For the years ended December 31, 2025 and 2024, the Company has a full valuation allowance against the deferred tax assets.

 

The components of the Company’s deferred tax assets and liabilities are as follows (in thousands):

Deferred Tax Assets and Liabilities

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

13,741

 

 

$

11,035

 

Tax credits carryforwards(1)

 

 

2,901

 

 

 

2,395

 

Stock-based compensation

 

 

648

 

 

 

517

 

Fixed assets/intangible assets

 

 

137

 

 

 

125

 

Charitable contributions

 

 

4

 

 

 

5

 

Capitalized research

 

 

2,387

 

 

 

2,706

 

Lease liability

 

 

55

 

 

 

79

 

Accruals and other

 

 

-

 

 

 

1

 

Gross deferred tax assets

 

 

19,873

 

 

 

16,863

 

Valuation allowance

 

 

(19,824

)

 

 

(16,784

)

Deferred tax assets

 

 

49

 

 

 

79

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of-use asset

 

 

(49

)

 

 

(79

)

Deferred tax liabilities

 

 

(49

)

 

 

(79

)

Net deferred tax asset

 

$

-

 

 

$

-

 

 

(1) Federal and state tax credit carryforward are presented net of certain liabilities for unrecognized tax benefits.

 

At December 31, 2025, valuation allowances against deferred tax assets in the U.S. totaled $19.8 million, an increase of $3.0 million from valuation allowance at December 31, 2024 of $16.8 million. The Company will maintain the valuation allowances until it determines it is more likely than not the deferred tax assets will be realized. The net increase in the deferred tax valuation allowance in 2025 is primarily attributable to federal and state net operating loss and foreign tax credits that the Company does not expect to realize.

 

At December 31, 2025, the Company had federal and state net operating loss (“NOL”) carryforward amounts of $49.5 million and $49.1 million, respectively. The federal NOL carryforwards consists of $4.7 million generated before January 1, 2018, which will begin to expire in 2030 but are able to offset 100% of taxable income and $44.9 million generated after December 31, 2017 which can be carried forward indefinitely and may be able to be used against 100%. The state NOL carryforward will begin to expire in 2033.

The utilization of the Company’s NOLs may be subject to a U.S. federal limitation due to the “change in ownership provisions” under Section 382 and 383 of the IRC and similar limitations for states. In general, under Section 382, a corporation that undergoes an “ownership change” (as defined under Section 382 of the Code and applicable Treasury

Regulations) is subject to limitations on its ability to utilize its pre-change NOLs to offset its future taxable income. As of December 31, 2025, the Company had not conducted an analysis of an ownership change under Section 382. To the extent that a study is completed, and an ownership change is deemed to occur, in the past or future, such limitations may result in a reduction of the amount of net operating loss carryforwards in future years and possibly the expiration of certain net operating loss carryforwards before their utilization.

As of December 31, 2025, the Company had federal and state tax credit carryforwards of $3.4 million which will begin to expire in 2033, and California tax credit carryforwards of $0.5 million which do not expire.

Uncertain Income Tax Positions

The total amount of unrecognized tax benefits as of December 31, 2025, is $1.0 million which relates to federal and state tax credits. The Company did not have tax-related interest and penalties at December 31, 2025. If recognized, none of the unrecognized tax benefits would affect the effective tax rate.

The following summarizes the activity related to the Company’s unrecognized tax benefits for the year ended December 31, 2025 (in thousands):

Schedule of Unrecognized Tax Benefits

 

 

 

Amount

 

Balance at January 1, 2025

 

 

827

 

Tax positions related to the current year:

 

 

 

Additions

 

 

195

 

Tax positions related to the prior year:

 

 

 

Reduction

 

 

(26

)

Balance at December 31, 2025

 

$

996

 

 

The Company’s policy is to account for interest and penalties as income tax expense. As of December 31, 2025, the Company had no interest related to unrecognized tax benefits. No amounts of penalties related to unrecognized tax benefits were recognized in the provision for income taxes. The Company does not anticipate any significant change within twelve months of this reporting date.

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company is subject to U.S. federal and state income tax examination for calendar tax years beginning in 2011 due to net operating losses that are being carried forward for tax purposes.

Following is a summary of income taxes paid (in thousands) by jurisdiction pursuant to the disclosure requirements of ASU No. 2023-09 for the period presented:

 

 

Year Ended
December 31,

 

 

2025

 

Jurisdiction

 

 

 

United States - Federal

 

$

-

 

United States - California

 

 

1

 

United States - New Jersey

 

 

-

 

United States - Other States

 

 

-

 

Foreign

 

 

-

 

Total cash paid for income taxes, net of refunds

 

$

1